| 摘要 |
PROBLEM TO BE SOLVED: To provide a novel therapeutic agent which can treat oxidative damage due to reactive oxygen species (ROS) and epigenetic abnormality simultaneously, particularly useful for the treatment of chronic obstructive pulmonary disease (COPD).SOLUTION: The present invention provides a complex for co-deliverying an antioxidant and a gene to an object, comprising a carrier capable of co-deliverying an antioxidant and a gene, an antioxidant, and a plasmid DNA. The carrier is preferably liposome, biodegradable polymer, or lipid-coated biodegradable polymer.SELECTED DRAWING: None |
